We turn breakthrough health technologies into products healthcare can actually use.
Lumen Health Group is the commercialization engine for the prevention economy. We take diagnostic, AI, and monitoring breakthroughs, prove them out in real clinical settings, and sell them through a channel that already reaches healthcare buyers.
How the engine works.
Most of healthcare buys technology one tool at a time and tries to stitch it together later. Lumen does the stitching first. We find prevention technology before it's commercially ready and bring it to market packaged and ready to deploy.
Source
We find the prevention breakthroughs early, in diagnostics, AI, and monitoring, and get access others can't.
Validate
Our clinical bench proves each technology out and designs the workflow that makes it usable in real care.
Productize
We package it into a named product built for one specific buyer, not a kit of parts to assemble.
Deliver
We sell it through channels we already run, and every deployment makes the next sale easier.
One product. A ladder of buyers.
The product barely changes as you move up the ladder. What changes is who's buying and how much rides on it. Concierge practices are the entry point, and every deployment makes the next sale up the ladder easier to land.
For practices
A turnkey prevention product concierge and DPC practices can deploy and mark up. It gives the practice something competitors don't have, plus a new line of revenue.
For practicesFor post-acute
The same product, aimed at high-consequence populations, with continuous monitoring built into the facility's workflow.
For post-acuteFor health systems
A packaged preventable-harm program built around the transition-of-care and quality measures health systems already report on.
For health systemsFor technology companies
Reach healthcare buyers by building your technology into a Lumen product we already sell.
For partnersFor investors
The go-to-market your portfolio companies would otherwise build from scratch, plus demand signal from the field.
For investorsWhat a competitor can't copy.
-
i.
It's already assembled.
You deploy one finished product. Wiring a dozen tools together is our job, not yours.
-
ii.
We run it, not just sell it.
Lumen operates the program end to end, so adopting it doesn't add headcount or a build burden on the buyer.
-
iii.
The combination is the hard part.
Any single piece can be bought or rebuilt. Having all of them in one validated, sellable product is what nobody has matched.
-
iv.
Engagement is the business.
Prevention only pays off when people stay engaged between visits. That follow-through compounds: they renew, upgrade, and bring others with them.
Healthcare is shifting from paying for volume to paying for outcomes.
That rewards the early-detection and engagement model that prevention is built on.
Lumen is built to move that technology into the market while the shift is still underway.
Good technology is everywhere. Getting it used is the hard part.
Talk to usA complete prevention program, without building one.
Lumen Protect gives concierge and direct primary care practices a prevention program they can offer members without building it. Diagnostics, monitoring, and follow-up are included.
An offering your members can't get elsewhere.
Most concierge practices promise prevention and deliver an annual physical. Real prevention takes a lot more: clinical workflow, lab integrations, monitoring devices, follow-up protocols, and a team to run all of it. Lumen brings the whole program, and your practice puts it in front of members.
-
i.
Something members can't find elsewhere.
Advanced screening and monitoring that sits outside what their existing care relationships offer.
-
ii.
A new revenue line.
A flat-fee structure your practice marks up. Lumen runs the operations; the member relationship and the margin stay with you.
-
iii.
Decision support, not replacement.
Lumen surfaces results, flags what needs attention, and handles the coordination. Your clinicians make the calls and keep the relationship.
-
iv.
Nothing to stand up.
Lumen Protect runs for your panel with no new hires and nothing to build — we operate it for you.
One program, delivered through your practice.
Members enroll through you. The program runs on Lumen's clinical workflow but reads to the member as part of your care. You keep the relationship; we run everything underneath.
Enrollment & logistics
We handle enrollment, scheduling, and sample collection, with mobile phlebotomy in supported regions.
Results in context
Lumen organizes and surfaces results with the context your clinicians need, then routes them to your team. The clinical decisions stay with you.
Follow-up coordination
When a finding needs next steps like imaging or a referral, we coordinate them with your practice and the member.
Offer your members a program you didn't have to build.
Talk to us about your practiceContinuous monitoring for post-acute patients, built into your workflow.
Lumen's post-acute program monitors patients across skilled nursing, long-term care, and home settings, with a clinical workflow that surfaces concerning changes to your team in real time.
Built for the post-acute transition window.
Post-acute patients are increasingly complex, and the window between a subtle change and an acute event is narrow. Between rounds, much of what happens to a patient goes unobserved. Lumen's program is built for that window.
A patient sliding toward a serious change can look stable between rounds.
By the time the shift is obvious, the window to respond inside the facility has often narrowed.
Continuous signal is what closes that gap.
Continuous monitoring, with the workflow built in.
Lumen monitors clinical signals continuously, from vitals to biomarkers to behavioral patterns, and pairs that with a workflow that surfaces concerning changes to your clinical team. The program is tuned to conditions like sepsis, pneumonia, and cardiac decompensation.
Detect
Biomarker analysis and screening tuned to the conditions most common in post-acute patients.
Monitor
Continuous physiologic signal between rounds, measured against each patient's own admission baseline.
Escalate
Concerning patterns reach the right clinical team in real time, with the context they need to respond.
What the program changes operationally.
-
i.
Continuous oversight between rounds.
Your clinical team sees concerning changes as they develop, not after the fact.
-
ii.
Documentation built to your standards.
Structured records of monitoring and response that your team and referring partners can review.
-
iii.
Oversight your partners can verify.
Documented monitoring and escalation, available to your referring hospitals on a set cadence.
-
iv.
Stronger referral relationships.
A documented prevention program your referring hospitals can point to when deciding where to send patients.
Monitoring and workflow, built for your facility.
Talk to us about your facility or networkThe 30 days after discharge, operated.
Lumen's post-discharge programs pair continuous monitoring with escalation workflows that surface what your care team needs to see across the 30-day transition window.
The post-discharge window is where programs fall apart.
The 30 days after discharge are when responsibility is most fragmented. Few systems can monitor patients through that window at any scale, and most point solutions handle one slice of it and leave you to wire up the rest.
Pilots like this tend to fail in the same spot.
The device or algorithm works fine. What never comes together is the workflow around it: who watches the data, who acts on it, and when.
Lumen builds that workflow into the program, which is why it behaves like an operating partner instead of one more vendor.
One program, discharge through recovery.
The same program covers surgical, medical, and cardiac patients. What changes is the clinical workflow, tuned to each cohort and the conditions that matter most inside the 30-day window.
-
i.
Continuous post-discharge monitoring.
Surgical, medical, and cardiac patients are monitored from discharge through recovery, with vitals, biomarkers, and behavioral signals measured against each patient's own baseline.
-
ii.
Escalation workflows.
Signs of decompensation reach the right clinical team in real time, with context and severity.
-
iii.
Signals that don't fall through the cracks.
Lumen surfaces post-discharge signals that often go unseen and routes them to your care team, alongside your existing discharge workflow.
-
iv.
Quality-measure alignment.
Documentation and reporting structured to CMS readmission measures and HCAHPS transition-of-care domains.
Integrated into your existing systems.
Lumen connects to your existing EHR and discharge workflow. Our team supports protocol design, clinician training, and ongoing operations, so you don't have to build internal capacity to run the program.
Connect
EHR integration over standard APIs (FHIR, HL7). Discharge events enroll patients automatically.
Configure
Clinical protocols mapped to your cohorts, specialists, and escalation pathways.
Operate
Lumen runs the program. Your clinical leadership keeps oversight, and your team sees program data on a set cadence.
One integration, and Lumen runs it from there.
Schedule a system-level conversationReach healthcare buyers through one product.
Lumen builds healthcare technologies into prevention programs and sells them through channels we already run: concierge medicine, post-acute care, health systems, and direct to patients. You keep your technology. We bring the buyers.
The part most teams underestimate.
Plenty of healthcare companies build something that works, then spend years and most of a funding round trying to land a single health-system pilot. Lumen is the commercial side they were missing, and it gets proven technology into paying accounts.
-
i.
Channel access.
Live clinical settings ready to sell into, from concierge practices to post-acute networks to health systems, without you standing up a sales team.
-
ii.
Workflow design.
We design the clinical motion that makes your technology a repeatable, billable program instead of a feature that sits idle until someone champions it.
-
iii.
Compliance fluency.
We know how AKS, Stark, HIPAA, and state requirements shape a program and build with them in mind. You stay responsible for your own technology's compliance; we help you navigate how it fits.
-
iv.
Revenue participation.
Built around how your technology deploys, whether that's a license, a commission, or a hybrid of the two.
How we decide what to integrate.
We take on only a handful of technologies a year. What we screen for isn't money; it's whether the thing is clinically sound, economically real, and the right structural fit. Anything that clears that bar is something we'll put our own channel behind.
-
01
Value-based care alignment.
It has to align with how value-based care actually works, not just shift cost between line items.
-
02
A real problem.
The clinical problem can't already be well solved by existing options. We don't bring buyers another me-too product.
-
03
Clinical validation.
Evidence that matches the intended use: research-grade where the regulatory path requires it, pragmatic where it doesn't.
-
04
Value for more than one party.
It has to work for the patient, the clinician, the payer, and the operator at once.
From diligence to integration.
Diligence
A clinical, economic, and operational review with your team, usually over about four weeks.
Pilot integration
We build it into a single Lumen program for cohort testing, with terms designed to prove clinical and commercial fit.
Full integration
Roll-out across the channels and programs that fit, under a full commercial agreement. You keep your technology, IP, and roadmap.
If your technology clears our bar, we put our channel behind it.
Apply to integrate with LumenWhere breakthrough technology meets a buyer.
Lumen already runs the go-to-market machinery your portfolio companies would otherwise spend years building: clinical relationships, channel access, workflow design, and a sales team already calling on healthcare buyers. And because we're in the field every week, we tend to see demand before it reaches a pitch deck.
When great science can't reach a buyer.
The pattern repeats across healthcare portfolios. A company with strong technology spends a year or more, and a good share of a round, chasing its first health-system pilot. By the time it finds traction it needs more money, or it becomes a write-down. What it lacked was commercial access, almost every time.
Lumen sits right where that breaks down.
We take technology that's cleared our bar and sell it through channels we already run.
For your portfolio, that's the whole commercial operation they were about to build from nothing.
Three ways to work with us.
-
i.
Commercial diligence.
A read from the field on whether a prospective investment is actually being adopted, who's buying, and what's blocking it. Delivered as a written memo.
-
ii.
Go-to-market integration.
We bring portfolio companies into Lumen's existing channels and programs. It runs as a real partnership, with shared upside, not a vendor contract.
-
iii.
Co-investment.
Vehicles built around technologies that fit the Lumen model, so our commercial interest and your capital point the same way.
Demand intelligence from the field.
We're selling across diagnostics, remote monitoring, clinical AI, and preventable harm every week. That vantage shows us what's getting adopted, what keeps dying at the same procurement step, and where buyers are signaling demand that hasn't reached market research yet.
Diagnostics
Blood, breath, and biomarker platforms, and which classes are clearing payer hurdles versus stalling at the clinical workflow.
Monitoring & AI
Remote monitoring and clinical AI adoption patterns across post-acute, surgical, and ambulatory care.
Preventable harm
The conditions behind the most serious avoidable acute episodes, and the technologies addressing them at the workflow level.
A signal you can underwrite.
We take on only a small share of what we look at. The bar is real clinical validity, economics that hold up under value-based care, and a buyer ready to adopt now. When something clears it and we put our own channel behind it, that's us betting our commercial reputation, not handing out an endorsement.
Demand intelligence from the field, and conviction you can put capital behind.
Start a portfolio conversationThe commercialization engine for the prevention economy.
Lumen Health Group takes prevention technology and does the unglamorous part: the clinical proof, the packaging, and the selling that gets it into real care.
Detection is rarely the gap. Commercialization is.
Many of the conditions that drive the most healthcare burden are ones medicine can already detect early. The gap is everything after detection: sourcing the technology, proving it, packaging it, and getting it used in daily care. That's the work, and it's where most companies fall short.
That's the part Lumen owns.
We take technology that's cleared our bar and turn it into a named product, sold through channels we already run, from concierge practices to health systems.
A buyer gets something ready to use, with no assembly required.
-
i.
Built for one buyer at a time.
Every product is shaped around a specific buyer and ready to use, so no one is left managing a pile of vendors.
-
ii.
We already have the channel.
We sell into clinical relationships we already run, so getting adopted isn't something we have to raise money to figure out.
-
iii.
Clinicians design it.
The people who'll run a program help build it, and the patients who'll use it shape how it works.
The four areas we work in.
Lumen works in four areas where prevention has the biggest gap between what's possible and what reaches patients. Every product we build sits in one of them and runs on the same underlying system.
Diagnostics
Early-detection screening across blood, breath, biomarker, and imaging, built into the workflow that makes a result something a clinician can act on.
Remote monitoring
Continuous signal capture between visits, measured against each patient's own baseline instead of a population average.
Clinical AI
Decision support and pattern recognition aimed at the moments where AI changes what happens to a patient, not just what gets written down.
Preventable harm
The conditions behind most avoidable acute episodes: sepsis, cardiac decompensation, surgical complications.
The team running the company.
Anne Carter
Anne founded Lumen to put prevention and the patient at the center of how healthcare adopts new technology. She leads the company's clinical and commercial strategy and builds the partnerships, across technology companies, clinical organizations, and health systems, that the Lumen ecosystem runs on.
Brandon Bogdalek
Brandon spent his career in medical device sales, marketing, and human factors before building and selling a healthcare go-to-market agency. He now leads the healthcare and life sciences practice at the holding company behind Lumen, and drives Lumen's commercialization work across concierge medicine, post-acute care, and health systems.
The clinicians who shape every program.
Lumen's clinical advisors help set program design and evidence standards, and they own the workflow that makes a technology usable in real care. They're part of building each program, not a panel we consult after the fact.
Christopher Tignanelli, MD
Trauma and critical care surgeon and Dean of Data Science at the University of Minnesota, with over 150 published papers and leadership of the Clinical AI Program. Chris guides Lumen's clinical design standards and evidence framework across every program.
If you operate somewhere in this picture, we want to talk.
Get in touchTell us what you're working on.
Practice, health system, technology company, or investor: we read and answer every message ourselves.
Send us a message.
A real person responds within one business day.